scholarly journals A direct high-throughput in Cell-ELISA for measuring infectivity of cytopathic and non-cytopathic bovine viral diarrhoea virus strains applied to the assessment of antiviral activity

2018 ◽  
Vol 260 ◽  
pp. 75-81 ◽  
Author(s):  
María Eugenia Quintana ◽  
Lucas Barone ◽  
María Belén Forlenza ◽  
Myrian Vanesa Trotta ◽  
Cecilia Turco ◽  
...  
2009 ◽  
Vol 20 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Mika Okamoto ◽  
Masashi Sakai ◽  
Yukinori Goto ◽  
Mohammed TA Salim ◽  
Chiaki Baba ◽  
...  

Background: A number of compounds were examined for their inhibitory effect on bovine viral diarrhoea virus (BVDV) replication in cell cultures and found that some cyclooxygenase (COX) inhibitors had antiviral activity against the virus. Methods: Determination of compounds for their anti-BVDV activity was on the basis of the inhibition of virus-induced cytopathogenicity in Mardin–Darby bovine kidney (MDBK) cells. Anti-hepatitis C virus (HCV) activity was assessed by the inhibition of viral RNA synthesis in the subgenomic HCV RNA replicon cells. Results: Among the test compounds, 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1 H-pyrazole (SC-560) was the most active against BVDV, and its 50% effective and cytotoxic concentrations were 10.9 ±2.8 and 93.9 ±24.5 μM in virus and mock-infected MDBK cells, respectively. The compound also suppressed BVDV RNA synthesis in a dose-dependent fashion. Studies on the mechanism of action revealed that SC-560 did not interfere with viral entry to the host cells. Furthermore, it was assumed that the antiviral activity of SC-560 was not associated with its inhibitory effect on COX. The combination of SC-560 and interferon-α was additive to synergistic in inhibiting BVDV replication. More importantly, the compound proved to be a selective inhibitor of HCV replication. Conclusions: SC-560 and its derivative might have potential as novel antiviral agents against HCV.


2001 ◽  
Vol 49 (1) ◽  
pp. 117-120 ◽  
Author(s):  
G. Kulcsár ◽  
P. Soós ◽  
L. Kucsera ◽  
R. Glávits ◽  
V. Pálfi

The biological properties of bovine viral diarrhoea virus (BVDV) strain Oregon C24V were studied after intranasal and subcutaneous infection of pregnant sows. This virus strain is widely used in Hungary for immunising cattle against bovine viral diarrhoea (BVD). Based upon the results of the clinical, gross pathological, histopathological and virological examinations it can be established that the given strain caused asymptomatic infection and serological conversion in sows that were in the second third of gestation. The virus caused clinically apparent disease in some of the piglets born at term, which indicates that it had crossed the placenta. More than half (57%) of the live-born piglets died within 60 days of birth. The sows and their progeny did not shed the virus. BVDV infection has great differential diagnostic importance in pigs, as classical swine fever (CSF) virus strains of reduced virulence cause similar clinical symptoms and gross and histopathological changes.


2008 ◽  
Vol 19 (1) ◽  
pp. 33-40 ◽  
Author(s):  
Alexander V Birk ◽  
Edward J Dubovi ◽  
Xianchao Zhang ◽  
Hazel H Szeto

2011 ◽  
Vol 6 (1) ◽  
pp. 101-109
Author(s):  
Oleg Radul ◽  
Natalia Sucman ◽  
Serghei Pogrebnoi ◽  
Alic Barba ◽  
Athina Geronikaki ◽  
...  

The synthesis and antiviral activity evaluation of new derivatives of 2-aminothiazole, 1,2,4-triazole, as well as oxindoles has been realized. The synthesized compounds exhibited different cytotoxicity, in particular, oxindols 4, 5 , 7 , 8 , 9, 10, 11, 12, 13, 58 as well as thiazole/triazole 73 and 75 turned out to be the most cytotoxic for MT-4 cell lines. The compounds 11, 12, 73, and 75 are more toxic than reference compound Efavirenz. As far as the antiviral activity is concerned, none of the title compounds turned out active against Reo-1, Sb-1, VSV, RSV, YFV and VV viruses. The results obtained against Bovine Viral Diarrhoea Virus (BVDV) showed that nine compounds (six from oxindol’s seria 6, 12, 13, 52, 56, 58 and three 73, 75, 77 of triazole homologues) resulted moderate active. Among all of them, the most potent compound was 52, with EC50 of 6.6 μM. Studies of effect of synthesized compounds against Coxsakie Virus (CVB-2) revealed that only two compounds, 13 and 73 exhibit moderate activity (EC50 >40 and >18 μM, respectively). It should be noticed that eleven compounds, 4, 5, 7, 8, 9, 10, 11, 12, 13, 58, and 75 showed moderate activity against HIV-1 (EC50 >16 – m >59μM).


2021 ◽  
Vol 188 (3) ◽  
pp. 187-196
Author(s):  
Caitlin A. Evans ◽  
Lucy Woolford ◽  
Farhid Hemmatzadeh ◽  
Michael P. Reichel ◽  
Peter D. Cockcroft

2021 ◽  
pp. 109047
Author(s):  
Laura Gallina ◽  
Michel C. Koch ◽  
Arcangelo Gentile ◽  
Ida Treglia ◽  
Cristiano Bombardi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document